FDA Adds Pulmonary Aspiration Warning to GLP-1 Label The FDA has recently updated the labels for all glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications used for weight loss and diabetes management, with a new safety warning
Appl Microbiol Biotechnol 101(5):21312141 Wilson AC, Thompson HJ, Schedin PJ, Gibson NW, Ganther HE (1992) Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage
People usually get the safest and most effective care by working closely with their primary care provider or a board-certified obesity medicine physician [if they can no longer afford the medication]
But one should never use supplements or powders as a replacement for whole foods
To give you an idea, here are just a few of the more common, and serious, health issues that are linked to being overweight and obese: Type 2 diabetes Cardiovascular disease, including high blood pressure and heart disease Sleep apnea Arthritis Depression Fatty liver disease Gallbladder disease Fertility issues Low testosterone Sexual dysfunction If youre overweight, youre at far greater risk for developing these conditions than someone of healthy weight
